Menu

  • Electrophysiology
  • Therapies & Procedures
  • Patient Care Portfolio

    • The Cobalt™ and Crome™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy - defibrillator (CRT-D) portfolio is enabled with 40 J energy availability on the first shock and every shock,1 extended longevity, and BlueSync™ technology, allowing for tablet-based programming and app-based remote monitoring to streamline the patient and provider experience.1 Select models include intrinsic antitachycardia pacing (iATP) which is the only automated and smart antitachycardia pacing (ATP) algorithm that provides individualized therapy in real time,2 exclusive algorithms to manage atrial fibrillation (AF), and compatibility with a simplified heart failure risk stratification tool to help meet the needs of physicians and their patients.​

    Cobalt™​

    ICDs and CRT-Ds with a collection of exclusive algorithms to manage AF, offer BlueSync™ technology, and CRT-Ds compatible with an automated heart failure risk stratification tool. ​

    View Cobalt™​ ICD View Cobalt™​ CRT-D

    Crome​™​

    ICDs and CRT-Ds enabled with BlueSync™ technology, extended longevity, 40 J on all shocks including first shock,1 and CRT-Ds compatible with an automated heart failure risk stratification tool.

    View Crome​™​ ICD View Crome™​ CRT-D

    Shock reduction​

    ​Intrinsic ATP™ (iATP) is the only automated and smart ATP algorithm that provides individualized therapy in real time.2​

    Proven technologies

    Discover exclusive algorithms to manage AF patients and optimize CRT delivery that help tailor therapy for each patient’s needs.

    Streamlined workflows​

    ICDs and CRT-Ds enabled with BlueSync™ technology, and CRT-Ds compatible with an automated heart failure risk stratification tool.